Showing 1 - 4 results of 4 for search 'Peter W Nickerson', query time: 0.02s
Refine Results
-
1
-
2
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design by Peter W. Nickerson, Georg A. Böhmig, Steve Chadban, Deepali Kumar, Roslyn B. Mannon, Teun van Gelder, James C. Lee, Scott Adler, Edward Chong, Arjang Djamali
Published 2022-12-01
Article -
3
HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity by N. Remi Shih, Thoa Nong, Cathi Murphey, Mayra Lopez-Cepero, Peter W. Nickerson, Jean-luc Taupin, Magali Devriese, Jakob Nilsson, Marie-Benedicte Matignon, Robert A. Bray, Jar-How Lee
Published 2024-01-01
Article -
4
Epidemiology of Epstein-Barr Virus Chronic High Viral Load in Kidney Transplant Recipients by Christie Rampersad, MD, Chris Wiebe, MD, Robert Balshaw, PhD, Jared Bullard, MD, Armelle Perez Cortes Villalobos, MD, Aaron Trachtenberg, MD, PhD, James Shaw, MD, PhD, Martin Karpinski, MD, Aviva Goldberg, MD, Patricia Birk, MD, Maury Pinsk, MD, David N. Rush, MD, Peter W. Nickerson, MD, Julie Ho, MD
Published 2024-03-01
Article